SequelSEC

Cronos Group Inc. CRON

Medicinal Chemicals & Botanical Products · CIK 0001656472 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$192.94M
Fiscal year ended 2026-06-30
Operating income
-$2.43M
Fiscal year ended 2026-06-30
Free cash flow
$49.82M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$379.90MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$1.00Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue2.6×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity0.3×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Medicinal Chemicals & Botanical Products filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
CapEx / revenue17.5%100th
Current ratio19.59x100th
Revenue YoY growth24.6%78th
R&D / revenue3.0%78th
SBC / revenue4.8%72th
Net margin-6.4%71th
Operating margin-11.9%38th
Gross margin42.8%45th
FCF margin0.1%50th

Cronos Group Inc. (CRON) reported revenue of $192.94M and net income of $69.98M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Cronos Group Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Medicinal Chemicals & Botanical Products.

Income

Cronos Group Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$192.94M
Cost of revenueUnavailable
Gross profit$82.12M
Operating income-$2.43M
Net income$69.98M
Research & development$5.36M
Weighted-average diluted sharesUnavailable
Pretax income$68.47M
Income tax expense-$10.73M
Diluted EPSUnavailable
Selling, general & administrative$68.94M
General & administrative$44.69M
Selling & marketing$24.25M

Balance

Cronos Group Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$467.02M
Total assets$1.18B
Current assets$912.03M
Total liabilities$62.42M
Current liabilities$56.36M
Total equity incl. NCI$1.12B
Temporary (mezzanine) equityUnavailable
Inventory$52.70M
Accounts receivable$36.72M
Goodwill$64.15M
Long-term debtUnavailable
Accounts payable$17.42M

Cash flow

Cronos Group Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$60.05M
Capital expenditures$10.24M
Investing cash flow-$340.49M
Financing cash flow-$48.44M
Net change in cash-$327.40M
Stock-based compensation$6.45M
Common dividends paidUnavailable
Common share repurchases$38.99M
Depreciation & amortization$4.86M

Derived

Cronos Group Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$49.82M
Gross margin42.6%
Operating margin-1.3%
FCF margin25.8%
SBC / revenue3.3%
Current ratio16.18x
Revenue YoY growth48.1%
Net margin36.3%
R&D / revenue2.8%
CapEx / revenue5.3%
Long-term debt / equityUnavailable
Effective tax rate-15.7%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CRON in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-11View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

AAWH ADIA AIBT BTMD CBDY CFOO CGC CHUC CYAN DFTX FTLF HYEX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.